Chemomab Therapeutics Ltd.
CMMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534248
In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Chemomab Therapeutics Ltd. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, $6.52K in total
- Insiders trading
- 1
- Net value
- −$6.52K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Chemomab Therapeutics Ltd., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Cohen Neil Harris | Director | 33,000 | Sep 1, 2026 | 1 |
| Mor George Adi | Chief Executive Officer | 18,750 | Jun 1, 2026 | 1 |
| Darvish Nissim | Director | 1,200 | Jul 5, 2023 | 0 |
| Quigley Jill M. | Director | – | Jun 20, 2023 | 0 |
| Fatal Sigal | Chief Financial Officer | – | Jun 16, 2023 | 0 |
| Nicaise Claude | Director | – | Mar 23, 2023 | 0 |
| Moses Alan Charles | Director | – | Mar 23, 2023 | 0 |
| OrbiMed Israel GP Ltd. | 10% Owner | 2,241,274Indirect | Jan 5, 2023 | 0 |
| OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | 2,241,274Indirect | Jan 5, 2023 | 0 |
| Marvin Donald | Executive VP, CFO & COO | 2,000 | Jun 21, 2022 | 0 |
| Maryles Joel Michael | Director | 1,433 | May 25, 2022 | 0 |
| Pfost Dale R | Chief Executive Officer | 2,500 | Mar 15, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 (view filing)10:05 AM ET | Aug 27-28 | 5 daysLate | Cohen Neil HarrisDirector | SSaleAmerican Depositary Shares | −2.30K | $2.83 | −$6.52K | −6.5%33.0K after | 2 lots |
| Jun 1, 2026 (view filing) | May 29 | 3 days | Mor George AdiChief Executive Officer | PPurchaseAmerican Depositary Shares | −9.80K | $2.07 | −$20.2K | −6.6%139.1K after | 2 lots |
| Jan 5, 2023 (view filing)4:49 PM ET | Jan 3 | 2 days | OrbiMed Israel GP Ltd. and 1 other10% Owner | SSaleAmerican Depository Shares | −336.9K | $3.58 | −$1.21M | −13.1%2.24M after | 2 lots |
| Jan 5, 2023 (view filing) | Jan 3 | 2 days | Mor George AdiChief Scientific Officer | SSaleAmerican Depositary Shares | −7.70K | $5.03 | −$38.7K | −2.4%317.1K after | |
| Jan 5, 2023 (view filing) | Jan 3 | 2 days | Mor George AdiChief Scientific Officer | SSaleAmerican Depositary Shares | −6.10K | $5.03 | −$30.7K | −2.4%251.1K after | |
| Nov 18, 2022 (view filing) | Nov 16 | 2 days | Cohen Neil HarrisDirector | SSaleAmerican Depositary Shares | −2.41K | $2.00 | −$4.82K | −19.4%10.0K after | |
| Nov 17, 2022 (view filing) | Nov 16 | 1 day | Mor George AdiChief Scientific Officer | SSaleAmerican Depositary Shares | −324.8K | $2.08 | −$675.5K | −50.0%324.8K after | |
| Nov 17, 2022 (view filing) | Nov 16 | 1 day | Mor George AdiChief Scientific Officer | SSaleAmerican Depositary Shares | −257.2K | $2.08 | −$535.1K | −50.0%257.2K after | |
| Jun 21, 2022 (view filing) | Mar 16 | 97 daysLate | Marvin DonaldExecutive VP, CFO & COO | PPurchaseAmerican Depositary Shares | +500 | $3.28 | +$1.64K | +33.3%2.00K after | 2 lots |
| May 25, 2022 (view filing) | May 24 | 1 day | Maryles Joel MichaelDirector | PPurchaseAmerican Depositary Shares | +433 | $2.88 | +$1.25K | +43.3%1.43K after | 2 lots |
| May 19, 2022 (view filing) | May 18 | 1 day | Cohen Neil HarrisDirector | PPurchaseAmerican Depositary Shares | +2.00K | $3.19 | +$6.38K | +19.2%12.4K after | |
| Mar 21, 2022 (view filing) | Mar 18 | 3 days | Maryles Joel MichaelDirector | PPurchaseAmerican Depositary Shares | +1.00K | $4.34 | +$4.34K | New position1.00K after | 2 lots |
| Mar 21, 2022 (view filing) | Mar 14 | 7 daysLate | Marvin DonaldExecutive VP, CFO & COO | PPurchaseAmerican Depositary Shares | +1.25K | $4.04 | +$5.04K | +500.0%1.50K after | 5 lots |
| Mar 15, 2022 (view filing) | Mar 14 | 1 day | Pfost Dale RChief Executive Officer | PPurchaseAmerican Depositary Shares | +2.50K | $3.98 | +$9.94K | New position2.50K after | 2 lots |
| Mar 15, 2022 (view filing) | Mar 14 | 1 day | Cohen Neil HarrisDirector | PPurchaseAmerican Depositary Shares | +6.00K | $4.35 | +$26.1K | +136.1%10.4K after | 3 lots |
| Mar 14, 2022 (view filing) | Mar 11 | 3 days | Darvish NissimDirector | PPurchaseAmerican Depositary Shares | +1.20K | $4.28 | +$5.14K | New position1.20K after | |
| Dec 8, 2021 (view filing) | Dec 6 | 2 days | Cohen Neil HarrisDirector | PPurchaseAmerican Depositary Shares | +2.00K | $7.43 | +$14.9K | +83.0%4.41K after |